Skip to main content
logo
Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
1.880
+0.020 (1.08%)
Sep 17, 2026, 4:00 PM EDT - Market closed

Century Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
3408786199303867
Market Cap Growth
704.52%1.14%-56.77%-34.34%-65.09%-
Enterprise Value
259-1-5877-6597
Last Close Price
1.880.991.013.325.1315.86

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-0.8013.0388.8858.19-
PB Ratio
1.460.550.531.081.002.19
P/TBV Ratio
1.720.700.681.081.002.19
P/OCF Ratio
----21.53-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
---34.33--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.170.270.330.260.160.06
Debt / EBITDA Ratio
-5.79----
Net Debt / Equity Ratio
-0.35-0.46-0.84-0.67-0.88-0.50
Net Debt / EBITDA Ratio
0.8537.931.111.112.312.17
Net Debt / FCF Ratio
0.920.701.231.2216.081.48
Asset Turnover
-0.380.020.010.01-
Quick Ratio
8.045.821.479.8110.6114.25
Current Ratio
8.285.971.509.9210.7214.57
Return on Equity (ROE)
-49.65%-5.98%-73.14%-56.07%-37.46%-40.81%
Return on Assets (ROA)
-23.51%-3.26%-23.67%-18.47%-16.75%-21.80%
Return on Capital Employed (ROCE)
-39.50%-7.40%-60.50%-36.50%-27.10%-22.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-32.25%-11.03%-147.38%-68.80%-43.28%-11.06%
FCF Yield
-25.88%-120.57%-128.42%-51.39%-5.47%-15.46%
Buyback Yield / Dilution
-67.40%-10.05%-32.60%-2.70%-78.30%-332.95%
SEC Filings: 10-K · 10-Q